End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.69 CNY | -0.41% | +19.48% | -38.67% |
05-16 | Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials | MT |
04-25 | Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.67% | 543M | |
-1.85% | 89.87B | |
-3.95% | 37.57B | |
-11.10% | 32.75B | |
+63.31% | 26.47B | |
-19.91% | 14.25B | |
-6.72% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+6.07% | 9.11B |
- Stock Market
- Equities
- 688319 Stock
- News Chengdu Olymvax Biopharmaceuticals Inc.
- Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials